Blue-shifted ancyromonad channelrhodopsins for multiplex optogenetics is a research paper published in eLife (2025). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R35GM140838
National Institutes of Health
Grant: S10OD032293
National Institutes of Health
Grant: U01NS118288
National Institutes of Health
Grant: RF1NS133657
National Institutes of Health
Grant: R61CA278458
National Institutes of Health
Grant: R01NS136027
Welch Foundation
Grant: AU-0009
Welch Foundation
Grant: Q-2016-20220331
Welch Foundation
Grant: Q-2016-20190330
Natural Sciences and Engineering Research Council of Canada
Grant: RGPIN-2018-04397
Natural Sciences and Engineering Research Council of Canada
Grant: RGPIN-2024-03857
University of Guelph
Grant: President's Research Assistantship
Natural Sciences and Engineering Research Council of Canada
Grant: USRA award
Natural Sciences and Engineering Research Council of Canada
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5U01NS118288-04
Molecular Engineering of Natural Light-Gated Chloride Channels for Optogenetic Inhibition
National Institutes of Health
Grant: 5R01NS136027-02
Red-shifted voltage indicators for two-photon all-optical physiology and multi-spectral imaging
National Institutes of Health
Grant: 5R61CA278458-02
A multiplexed high-throughput platform to report pharmacologic alteration of cancer stem cell membrane potential and cell cycle state
National Institutes of Health
Grant: 1RF1NS133657-01
Developing an Optogenetics Technology Based on Natural Potassium-selective Channelrhodopsins
National Institutes of Health
Grant: 1S10OD032293-01
High-Throughput Automated Patch Clamp System
National Institutes of Health
Grant: 5R35GM140838-05
Structure/Function of Channelrhodopsins and Related Retinylidene Proteins
FWCI
1.43
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords